Jill Andersen - Nov 1, 2021 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Legal Officer, Secretary
Signature
/s/ Dorothy Vinsky, Attorney-in-Fact
Stock symbol
IVVD
Transactions as of
Nov 1, 2021
Transactions value $
$0
Form type
4
Date filed
11/2/2021, 06:02 PM
Next filing
Feb 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +515K $0.00 515K Nov 1, 2021 Common Stock 515K $30.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter (1/4) of the option shall vest on November 1, 2022, and thereafter, the remainder of the option shall vest in 36 equal monthly installments on the 1st day of each month, subject to the Reporting Person's continuous service on each vesting date.